Achillion Pharmaceuticals Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Achillion Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Achillion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical indicators, Achillion Pharmaceuticals is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
| Quick Ratio | 0.02 | |
| Fifty Two Week Low | 0.2000 | |
| Target High Price | 6.30 | |
| Fifty Two Week High | 0.5100 | |
| Target Low Price | 6.30 |
Achillion |
Achillion Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in Achillion Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 100.00 from holding Achillion Pharmaceuticals or generate -100.0% return on investment over 90 days. Achillion Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Achillion, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Achillion Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Achillion Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Achillion Pharmaceuticals, and traders can use it to determine the average amount a Achillion Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ACHN |
Based on monthly moving average Achillion Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Achillion Pharmaceuticals by adding Achillion Pharmaceuticals to a well-diversified portfolio.
Achillion Pharmaceuticals Fundamentals Growth
Achillion Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Achillion Pharmaceuticals, and Achillion Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Achillion Pink Sheet performance.
| Return On Equity | -0.0023 | |||
| Return On Asset | -115.43 | |||
| Operating Margin | (586.17) % | |||
| Current Valuation | 6.21 M | |||
| Shares Outstanding | 30 M | |||
| Price To Earning | (23.49) X | |||
| Price To Book | 4.00 X | |||
| Price To Sales | 710.14 X | |||
| Revenue | 8.7 K | |||
| EBITDA | (43.34 K) | |||
| Cash And Equivalents | 1.44 K | |||
| Total Debt | 61 K | |||
| Debt To Equity | 1.00 % | |||
| Cash Flow From Operations | (39.76 K) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 464.52 M | |||
| Retained Earnings | (653.45 M) | |||
| Current Asset | 462.59 M | |||
| Current Liabilities | 14.66 M | |||
Things to note about Achillion Pharmaceuticals performance evaluation
Checking the ongoing alerts about Achillion Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Achillion Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Achillion Pharmaceuticals is not yet fully synchronised with the market data | |
| Achillion Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Achillion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Achillion Pharmaceuticals currently holds 61 K in liabilities with Debt to Equity (D/E) ratio of 1.0, which is about average as compared to similar companies. Achillion Pharmaceuticals has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Achillion Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Achillion Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Achillion Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Achillion to invest in growth at high rates of return. When we think about Achillion Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 8.7 K. Net Loss for the year was (51 K) with profit before overhead, payroll, taxes, and interest of 7.87 K. | |
| Achillion Pharmaceuticals currently holds about 1.44 K in cash with (39.76 K) of positive cash flow from operations. | |
| Roughly 98.0% of Achillion Pharmaceuticals shares are held by company insiders |
- Analyzing Achillion Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Achillion Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Achillion Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Achillion Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Achillion Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Achillion Pharmaceuticals' pink sheet. These opinions can provide insight into Achillion Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Achillion Pink Sheet
If you are still planning to invest in Achillion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achillion Pharmaceuticals' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |